全文获取类型
收费全文 | 64117篇 |
免费 | 4481篇 |
国内免费 | 212篇 |
专业分类
耳鼻咽喉 | 799篇 |
儿科学 | 1409篇 |
妇产科学 | 843篇 |
基础医学 | 8155篇 |
口腔科学 | 954篇 |
临床医学 | 6815篇 |
内科学 | 13878篇 |
皮肤病学 | 789篇 |
神经病学 | 6403篇 |
特种医学 | 2186篇 |
外国民族医学 | 5篇 |
外科学 | 11475篇 |
综合类 | 625篇 |
一般理论 | 47篇 |
预防医学 | 4370篇 |
眼科学 | 1232篇 |
药学 | 4406篇 |
中国医学 | 71篇 |
肿瘤学 | 4348篇 |
出版年
2024年 | 64篇 |
2023年 | 499篇 |
2022年 | 870篇 |
2021年 | 2008篇 |
2020年 | 1211篇 |
2019年 | 1797篇 |
2018年 | 2187篇 |
2017年 | 1533篇 |
2016年 | 1632篇 |
2015年 | 1875篇 |
2014年 | 2703篇 |
2013年 | 3363篇 |
2012年 | 5252篇 |
2011年 | 5449篇 |
2010年 | 2928篇 |
2009年 | 2690篇 |
2008年 | 4383篇 |
2007年 | 4475篇 |
2006年 | 4262篇 |
2005年 | 4068篇 |
2004年 | 3628篇 |
2003年 | 3462篇 |
2002年 | 3089篇 |
2001年 | 418篇 |
2000年 | 315篇 |
1999年 | 386篇 |
1998年 | 615篇 |
1997年 | 481篇 |
1996年 | 379篇 |
1995年 | 326篇 |
1994年 | 288篇 |
1993年 | 269篇 |
1992年 | 199篇 |
1991年 | 159篇 |
1990年 | 128篇 |
1989年 | 110篇 |
1988年 | 114篇 |
1987年 | 96篇 |
1986年 | 90篇 |
1985年 | 81篇 |
1984年 | 118篇 |
1983年 | 97篇 |
1982年 | 108篇 |
1981年 | 99篇 |
1980年 | 112篇 |
1979年 | 46篇 |
1978年 | 47篇 |
1977年 | 45篇 |
1976年 | 33篇 |
1974年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
Firouzan Massoomi Pharm.D. John Savage Pharm.D. Christopher J. Destache Pharm.D. 《Pharmacotherapy》1993,13(1):46-59
Omeprazole is a member of a new class of substituted benzimidazoles. These agents inhibit the proton pump in the gastric parietal cell, blocking the final step in the gastric acid secretory pathway. Omeprazole has been investigated for the treatment of gastric ulcer, duodenal ulcer, gastroesophageal reflux, and various hypersecretory states. The prolonged inhibition of gastric acid secretion allows for once-daily dosing in patients with peptic ulcer disease and gastroesophageal reflux, and once- or twice-daily dosing in patients with Zollinger-Ellison syndrome. Compared with currently available therapies, omeprazole is well tolerated and demonstrates a more rapid ulcer healing rate. It is superior to conventional therapies in the treatment of Zollinger-Ellison syndrome. Side effects are infrequent when the drug is used for the short-term management of ulcers. 相似文献
32.
Despite the widespread use of botulinum toxin to treat muscle dystonias, no method exists to quantify muscle paralysis in either human or nonhuman models. In this study we examined how the location, dose, and volume of botulinum injection affects paralysis in the rat tibialis anterior muscle. Paralysis was quantified by electrically stimulating the nerve to the tibialis anterior and then staining sections of the muscle for glycogen. The areas of glycogen-containing fibers represented regions of botulinum action. The results showed that the most important injection technique is to inject botulinum directly into the motor endplate region of a muscle. Injections only 0.5 cm from the motor endplate resulted in a 50% decrease in paralysis. Increases in dose increased paralysis, however, some of that increase was simply due to the increased volume of injection. Thus, delivering toxin in small volumes near the MEP band of a muscle should produce the most effectiveparalysis. © 1993 John Wiley & Sons, Inc. 相似文献
33.
34.
Barbara A. Bresnahan Christopher P. Johnson Matthew J. McIntosh Donald Stablein Sundaram Hariharan 《American journal of transplantation》2002,2(4):366-372
The optimal allocation of cadaveric kidneys for transplantation with reference to human leukocyte antigen (HLA) match and sharing these organs to a distant center remains controversial. The current analysis was performed using the United Network for Organ Sharing (UNOS) database for cadaveric kidney transplants (Tx) between 1988 and 1997. The graft survivals of zero-mismatch (matched) kidneys with the mate (mismatched) kidneys were compared. There were 2385 donors and 4770 Tx. Significant differences in recipient demographics between matched and mismatched Tx were: fewer African-American race (AA) in the matched group (9.0% vs. 21.9%), higher number of previous Tx (25.5% vs. 14.8%) and elevated mean cold ischemia time (24.0 vs. 22.2 h). Post-Tx dialysis requirements were similar (22.8% vs. 24.1%, p = 0.62) and matched kidneys had to travel more distance (920 vs. 232 miles). Using a Cox model, the matched group had a decreased relative hazard of graft failure of 23.0% (p = 0.0002) or 35% (p < 0.0001) with and without censoring for death. There was significantly better graft survival in the matched recipients in all pairs except AA (matched) and non-AA (mismatched). For older donors (> or = 50 years, n = 1508), the matched grafts survival was marginally significant (p =0.05). Matched kidneys have improved survival compared with the mismatched kidneys despite the longer distance traveled. The benefit of mismatched transplants was predominantly seen in non-AA. 相似文献
35.
36.
Christopher Gillberg 《Journal of autism and developmental disorders》1991,21(1):61-77
Autism is associated with epilepsy. One third of the population of people with autism have developed seizures in early adult life. In spite of this well-known association, little is known about the treatment of epilepsy in autism. This paper reviews the sparse literature and reports a systematic case-record study of the treatment of epilepsy in autism. Some practical guidelines for clinicians are provided. Research in the field of epilepsy in autism is highly warranted.This study has been supported by a grant from The Commission for Social Research, Sweden, No. E 88/170:2. 相似文献
37.
38.
39.
40.
Guerard W. Byrne Johannes M. Schirmer David N. Fass Sumeet S. Teotia Walter K. Kremers Hui Xu Bashoo Naziruddin Henry D. Tazelaar John S. Logan Christopher G. A. McGregor 《American journal of transplantation》2005,5(5):1011-1020
Microvascular thrombosis is a prominent feature in cardiac delayed xenograft rejection (DXR). We investigated the impact of warfarin or low-molecular-weight heparin (LMWH) anti-coagulation on xenograft function using a heterotopic pig-to-primate model. Donor hearts were from CD46 transgenic pigs and baboon immunosuppression included tacrolimus, sirolimus, anti-CD20 and TPC, an alpha-galactosyl-polyethylene glycol conjugate. Three groups of animals were studied. Group 1 (n = 9) was treated with warfarin, Group 2 (n = 13) with LMWH and Group 3, received no anti-coagulant drugs. The median duration of xenograft function was 20 days (range 3-62 days), 18 days (range 5-109 days) and 15 days (range 4-53 days) in Groups 1 to 3 respectively. Anti-coagulation achieved the targeted international normalized prothrombin ratio (INR) and anti-factor Xa levels consistent with effective in vivo therapy yet, no significant impact on median xenograft function was observed. At rejection, a similar histology of thrombosis and ischemia was apparent in each group and the levels of fibrin deposition and platelet thrombi in rejected tissue was the same. Anti-coagulation with warfarin or LMWH did not have a significant impact on the onset of DXR and microvascular thrombosis. However, a role for specific anti-coagulant strategies to achieve long-term xenograft function cannot be excluded. 相似文献